Information  X 
Enter a valid email address

Tristel PLC (TSTL)

  Print          Annual reports

Wednesday 02 December, 2020

Tristel PLC

Update to Executive Performance Share Plan 2021

RNS Number : 2801H
Tristel PLC
02 December 2020

Tristel plc

("Tristel" or the "Company")


Update to Executive Performance Share Plan 2021


Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that the terms of the options to be granted under the rules of the Tristel plc Executive Performance Share Plan 2021 (the "Plan") to be put to shareholders for approval at the Annual General Meeting of the Company to be held on 10.00 a.m. on 15 December 2020 (the "AGM") will be amended to include more onerous performance targets for the vesting of the options. 


A revised copy of Appendix I of the Notice of AGM summarising the principal terms of the Plan and of the options to be granted under the Plan and copies of the proposed option agreements incorporating, in each case, the more onerous performance targets, together with the full text of the Plan, the Notice of AGM and the Form of Proxy, are available for inspection on the Company's website at


Any shareholder who wishes to change any proxy instructions already submitted, may do so by submitting a new proxy appointment using the methods set out in the notes to the Notice of AGM.


Shareholders are reminded that proxies must be received no later than 10.00 a.m. on 11 December 2020.







For further information please contact: 


Tristel plc

Tel: 01638 721 500

Paul Swinney, Chief Executive Officer

Liz Dixon, Finance Director

Walbrook PR Ltd

Tel: 020 7933 8780 or [email protected]

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07584 391 303


Tel: 020 7220 0500

Geoff Nash/ Giles Rolls (Corporate Finance)

Alice Lane (ECM)



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t